Post navigation

After decades of relative neglect, star-shaped brain cells called astrocytes are getting their due. To gather insight into a critical aspect of brain development, a team of scientists examined the maturation of astrocytes in 3-D structures grown in culture dishes to resemble human brain tissue. The study, which confirms the lab-grown cells develop at the same rate as those found in human brains, was published in Neuron and funded in part by the National Institutes of Healths National Institute of Neurological Disorders and Stroke.

This work addresses a significant gap in human brain research by providing an invaluable technique to investigate the role of astrocytes in both normal development and disease, said NINDS program director Jill Morris, Ph.D.

In 2015, a team directed by Dr. Sergiu Pasca, an assistant professor of psychiatry and behavioral science at Stanford University in California, and Dr. Ben Barres, Ph.D., a Stanford professor of neurobiology, published a method for taking adult skin cells, converting them to induced pluripotent stem cells, and then growing them as 3-D clusters of brain cells called human cortical spheroids (hCSs). These hCSs, which closely resemble miniature versions of a particular brain region, can be grown for many months. The cells in the cluster eventually develop into neurons, astrocytes, and other cells found in the human brain.

One of the challenges of studying the human brain is the difficulty of examining it at different stages of development, Dr. Pasca said. This is a system that tries to simulate brain development step by step.

In the new study, Steven Sloan, a student in Stanfords M.D./Ph.D. program, led a series of experiments comparing astrocytes from hCSs to those found in tissue from the developing and adult human brain. The team grew the hCSs for 20 months, one of the longest-ever studies of lab-grown human brain cells.

The results verified that the lab-grown cells change over time in a similar manner to cells taken directly from brain tissue during very early life, a critical time for brain growth. This process is considered critical for normal brain development and deviations are thought to cause a variety of neurological and mental health disorders, such as schizophrenia and autism. Creating hCSs using cells from patients could allow scientists to uncover the underlying developmental biology at the core of these disorders.

The hCS system makes it possible to replay astrocyte development from any patient, Dr. Barres said. Thats huge. Theres no other way one could ever do that without this method.

The current study showed that hCS-grown astrocytes develop at the same rate as those found in human brains, in terms of their gene activity, their shapes, and their functions. For example, astrocytes taken from hCSs that were less than six months old multiplied rapidly and were highly engaged in eliminating unnecessary connections between neurons, just like astrocytes in babies growing in the womb. But astrocytes grown in hCSs for more than nine months could not reproduce and removed significantly fewer of those connections, mirroring astrocytes in infants 6 to 12 months old. On the other hand, just like astrocytes from developing and adult brains, the early- and late-stage astrocytes from hCSs were equally effective at encouraging new connections to form between neurons.

Astrocytes are not just bystanders in the brain, Dr. Pasca said. Theyre not just there to keep neurons warm; they actually participate actively in neurological function.

Since astrocytes make up a greater proportion of brain cells in humans than in other species, it may reflect a greater need for astrocytes in normal human brain function, with more significant consequences when they dont work correctly, added David Panchision, Ph.D., program director at the National Institute of Mental Health (NIMH), which also helped fund the study.

The researchers caution that hCSs are only a model and lack many features of real brains. Moreover, certain genes that are active in fully mature astrocytes never switched on in the hCS-grown astrocytes, which they could conceivably do if the cells had more time to develop. To address this question, the researchers now hope to identify ways to produce mature brain cells more quickly. hCSs could also be used to scrutinize precisely what causes astrocytes to change over time and to screen drugs that might correct any differences that occur in brain disease.

These are questions that are going to be very exciting to explore, Dr. Barres said.

The study was funded by NINDS, the National Institute of Mental Health, the National Institute of General Medical Sciences, the National Center for Advancing Translational Sciences, the California Institute of Regenerative Medicine, the MQ Fellow Award, and Stanford University.

The NINDS is the nations leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.

The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery and cure. For information, visit the NIMH website.

The National Institute of General Medical Sciences supports basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment and prevention. For information, visit the NIGMS website.

The National Center for Advancing Translational Sciences (NCATS) was established to transform the translational process so that new treatments and cures for disease can be delivered to patients faster. For information, visit the NCATS website.

The National Institutes of Health, the nation's medical research agency, encompasses 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For information about NIH and its programs, visit http://www.nih.gov.